The KDIGO Clinical Practice Guideline for Management of Autosomal Dominant Polycystic Kidney Disease (ADPKD) represents the first KDIGO guideline on this subject. The goal of the guideline is to generate a useful resource for clinicians and patients by providing actionable recommendations with infographics based on a rigorous, formal systematic literature review. Another aim is to propose research recommendations for areas in which there are gaps in knowledge.
KDIGO cordially invites you to share your feedback on the Scope of Work for the ADKPD Guideline. The Scope of Work is designed to briefly describe the rationale for the development of the guideline for the management of patients with ADPKD and to outline the topics that this guideline intends to address.
To do so, please download the Scope of Work document in the Downloads section and share your thoughts and comments via the feedback form below.
Kindly submit your feedback no later than March 1, 2021. Thank you for your time and input.
DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES
This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.